ORG Partners’s Novo Nordisk NVO Stock Holding History

ORG Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$12.2K	Sell	240 -460	-66%	-$23.5K	﹤0.01%	932
2025 Q3	$38.8K	Hold	700	–	–	0.01%	646
2025 Q2	$48.9K	Hold	700	–	–	0.01%	544
2025 Q1	$47.6K	Sell	700 -303	-30%	-$25K	0.01%	494
2024 Q4	$86.3K	Buy	1,003 +647	+182%	+$70K	0.01%	456
2024 Q3	$42.4K	Sell	356 -1,973	-85%	-$263K	0.01%	547
2024 Q2	$338K	Buy	2,329 +363	+18%	+$48.1K	0.04%	309
2024 Q1	$251K	Buy	+1,966	New	+$234K	0.48%	35
2023 Q4	–	Sell	-51	Closed	-$4.64K	–	1276
2023 Q3	$4.64K	Sell	51 -43	-46%	-$3.79K	﹤0.01%	963
2023 Q2	$8K	Buy	+94	New	+$7.68K	﹤0.01%	1014

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ORG Partners's NVO Position: Q4 2025 in Review

ORG Partners reduced its Novo Nordisk (NVO) stake by 66% in Q4 2025, selling an estimated $23.5K and leaving 240 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

ORG Partners first reported a position in NVO in Q2 2023 and has held it in 10 quarters since. The position peaked at $338K in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

ORG Partners held 240 shares of Novo Nordisk worth $12.2K as of Q4 2025.
ORG Partners sold 460 Novo Nordisk shares in Q4 2025, an estimated $23.5K.
Novo Nordisk made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #932 holding.
ORG Partners first reported a position in Novo Nordisk in Q2 2023 and has held it in 10 quarters since.
ORG Partners's Novo Nordisk position peaked at $338K in Q2 2024.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.